Evidence map›Paper›PMID 20818386›Full record

ArticleNature neuroscience2010

Pet-1 is required across different stages of life to regulate serotonergic function.

Chen Liu, Takashi Maejima, Steven C Wyler, Gemma Casadesus, Stefan Herlitze, Evan S Deneris

Abstract read
In one paragraph

Article in Nature neuroscience, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Science translational medicine · 2025
    Article
  13. Decoding serotonin: the molecular symphony behind depression.Frontiers in cellular neuroscience · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chen LiuCase Western Reserve University, School of Medicine, Department of Neurosciences, Cleveland, Ohio, USA.
Takashi Maejima
Steven C Wyler
Gemma Casadesus
Stefan Herlitze
Evan S Deneris

Funding

Project 6 Interactions of Serotonin and Circadian Signaling NetworksP50MH078028 · NIMH · VANDERBILT UNIVERSITY · PI DENERIS, EVAN S · 2007 to 2011
$9.8M
PET 1 ETS FACTOR IN THE MAMMALIAN 5 HT SYSTEMR01MH062723 · NIMH · CASE WESTERN RESERVE UNIVERSITY · PI DENERIS, EVAN S · 2001 to 2021
$8.3M
NIMH NIH HHS MH062723NIMH NIH HHS MH078028NIMH NIH HHS P50 MH078028NIMH NIH HHS R01 MH062723
6 · The paper itself

Abstract

Transcriptional cascades are required for the specification of serotonin (5-HT) neurons and behaviors modulated by 5-HT. Several cascade factors are expressed throughout the lifespan, which suggests that their control of behavior might not be temporally restricted to programming normal numbers of 5-HT neurons. We used new mouse conditional targeting approaches to investigate the ongoing requirements for Pet-1 (also called Fev), a cascade factor that is required for the initiation of 5-HT synthesis, but whose expression persists into adulthood. We found that Pet-1 was required after the generation of 5-HT neurons for multiple steps in 5-HT neuron maturation, including axonal innervation of the somatosensory cortex, expression of appropriate firing properties, and the expression of the Htr1a and Htr1b autoreceptors. Pet-1 was still required in adult 5-HT neurons to preserve normal anxiety-related behaviors through direct autoregulated control of serotonergic gene expression. These findings indicate that Pet-1 is required across the lifespan of the mouse and that behavioral pathogenesis can result from both developmental and adult-onset alterations in serotonergic transcription.

Indexed as

8-Hydroxy-2-(di-n-propylamino)tetralinAge FactorsAnalysis of VarianceAnimalsAnimals, NewbornCell DifferentiationChromatin ImmunoprecipitationEstrogen AntagonistsExcitatory Amino Acid AntagonistsExtracellular Matrix ProteinsGene Expression Regulation, DevelopmentalIn Vitro TechniquesLuminescent ProteinsMaleMaze LearningMice8-Hydroxy-2-(di-n-propylamino)tetralinEstrogen AntagonistsExcitatory Amino Acid AntagonistsExtracellular Matrix ProteinsFev protein, mouseLox protein, mouseLuminescent ProteinsProtein-Lysine 6-OxidaseReceptor, Serotonin, 5-HT1AReceptor, Serotonin, 5-HT1BRNA, MessengerSerotoninSerotonin Plasma Membrane Transport ProteinsSerotonin Receptor AgonistsSlc6a4 protein, mouseTamoxifenTexas redTranscription FactorsTryptophan HydroxylaseXanthenes

Identifiers

PMID20818386
PMCPMC2947586

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.